The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation...
Pierre Fabre Dermatologie Laboratories have, on 6 May 2014, obtained European Commission authorization to market Hemangiol (propranolol), the first and...